E

Evoke Pharma

D
EVOK
USD
-0.14
(-2.4476%)
Market Closed
6,555.00
Volume
-0.12
EPS
-
Div Yield
-0.381372
P/E
4,571,537.76
Market Cap
Today
-2.4476%
1 Week
-4.940%
1 Month
5.085%
6 Months
-3.607%
12 Months
-61.570%
Year To Date
-55.288%
All Time
-79.287%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Volkswagen Shares Wobble Amid Unstable EV Demand

10.07.2024
Stocks news

European Nations Vie for Chinese EV Factories with Incentives

11.06.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Phone Maker Xiaomi Bets Big on Electric Vehicles

26.02.2024
Economy news
More
Related Instruments
A
ABUS
-0.195
(-4.9618%)
USD
O
OCUL
-0.14
(-1.2809%)
USD
A
AKTX
0.07
(3.0043%)
USD
A
ADMP
(%)
USD
P
PLX
-0.05
(-4.065%)
USD
S
SELB
-0.0702
(-7.3871%)
USD
V
VNRX
0.0851
(14.0964%)
USD
T
TTNP
0.08
(2.0101%)
USD
N
NVAX
0.23
(2.5713%)
USD

Title:
Evoke Pharma, Inc.

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Do you need help or have a question?
Contact Us